Acadia Healthcare (ACHC) Upgraded by BidaskClub to Buy

Share on StockTwits

BidaskClub upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a buy rating in a report released on Wednesday morning, BidAskClub reports.

Several other brokerages also recently issued reports on ACHC. BMO Capital Markets lifted their price objective on Acadia Healthcare from $33.00 to $36.00 and gave the company a market perform rating in a research report on Wednesday, May 1st. Zacks Investment Research upgraded Acadia Healthcare from a sell rating to a hold rating in a research report on Thursday, January 24th. Mizuho set a $30.00 target price on Acadia Healthcare and gave the company a hold rating in a research note on Friday, January 25th. ValuEngine raised Acadia Healthcare from a strong sell rating to a sell rating in a research note on Wednesday, April 24th. Finally, Citigroup lowered their target price on Acadia Healthcare from $43.00 to $38.00 and set a buy rating for the company in a research note on Monday, March 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of $36.80.

Shares of ACHC opened at $32.71 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 1.55. Acadia Healthcare has a 52-week low of $24.27 and a 52-week high of $45.35. The firm has a market capitalization of $2.89 billion, a price-to-earnings ratio of 14.60, a price-to-earnings-growth ratio of 1.78 and a beta of 0.70.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. Acadia Healthcare had a positive return on equity of 7.33% and a negative net margin of 6.50%. The firm had revenue of $760.60 million during the quarter, compared to the consensus estimate of $762.02 million. During the same quarter in the previous year, the company posted $0.52 EPS. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. On average, equities research analysts forecast that Acadia Healthcare will post 2.21 earnings per share for the current year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ellington Management Group LLC increased its stake in shares of Acadia Healthcare by 0.7% in the 1st quarter. Ellington Management Group LLC now owns 44,236 shares of the company’s stock valued at $1,297,000 after buying an additional 309 shares during the period. Private Capital Group LLC grew its stake in shares of Acadia Healthcare by 67.3% during the first quarter. Private Capital Group LLC now owns 865 shares of the company’s stock worth $25,000 after purchasing an additional 348 shares during the period. SG Americas Securities LLC grew its stake in shares of Acadia Healthcare by 4.3% during the first quarter. SG Americas Securities LLC now owns 8,983 shares of the company’s stock worth $263,000 after purchasing an additional 368 shares during the period. Xact Kapitalforvaltning AB grew its stake in shares of Acadia Healthcare by 2.8% during the fourth quarter. Xact Kapitalforvaltning AB now owns 14,574 shares of the company’s stock worth $375,000 after purchasing an additional 400 shares during the period. Finally, BB&T Corp grew its stake in shares of Acadia Healthcare by 0.9% during the fourth quarter. BB&T Corp now owns 53,635 shares of the company’s stock worth $1,379,000 after purchasing an additional 455 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Featured Article: Day Trading – Risk Worth the Reward?

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report